ID: MRFR/Pharma/3388-CR | 113 Pages | Author: Rahul Gotadki | November 2017
Embolization Particle Market is expected to grow USD 1,430.5 Million at a CAGR 14.20% during the forecast period 2022-2030.
The embolization particle market is projected to reach USD 1,430.5 Million by 2030 at 14.20% CAGR during the forecast period 2022-2030. The concept of embolization is a minimally invasive therapy; Embolization Particle is an advanced concept which aims to stop not only bleeding but also means to stop blood flow to a tumor in a scientific order to shrink it or in preparation for complete removal. Embolization Particle, this advanced procedure, few embolized particles or tiny substances are rigorously injected into the vital veins of the clinic’s patients to completely block or eliminate the blood flow to typical cancer cells. The method of embolization is an option for very few patients with already existing tumors that cannot be completely removed by modern surgery. Embolization Particles can be used for treating tumors that are extremely large to be treated with modern ablation (usually larger than 5 cm thickness) processes. Embolization Particles can also be used with ablation. Embolization, without any doubt, does reduce a few of the blood supply to the normal liver tissue which is consisting inside the body, so it may not be a suitable option for a few of the patients whose liver has been busted by diseases such as critical illnesses related to hepatitis or cirrhosis. Embolization Particle is applied in various procedures as a major section of modern interventional radiology.
The embolization particle market is projected to have a healthy expansion during the estimated period. The continuous growing use of this modern embolization technique is an enhanced treatment for various conditions other than cancer diseases such as vascular malformations, and fibrosis which is contributing to the growth of the demand for embolization particles globally. Uninterrupted introduction of technically sound and advanced products with augmented efficiency is also aiding the global market growth.
There has been a constantly increasing demand for modern technology, which expands the major demand for uterine artery embolization particle size; there are plenty of advantages over traditional ones, and rising demand for the embolization particle market, also because lack of proper infrastructure are few of the primary drivers for the embolization particle market share. The large part of Europe is estimated to be the quickest growing area.
COVID 19 Impacts and effects
The COVID 19 has affected 215 countries and the embolization particle market analysis as well. To combat the negative effects, countries lead lockdowns that have adversely affected the embolization particle market. The pandemic leads to several challenges to the sector; it is affected all over the world. Plenty of factors like the risk of uninterrupted production, supply chain, distribution, lack of workforce employees, and much-decreased development activities have primarily affected the ongoing demand and supply. People are not as active as earlier. Major strategic developments are taking place. MNC are investing more in the embolization particle market of the increasing demand from consumers across the globe.
According to the data of World Health Organization, around 17.7 million people died every year from cardiovascular diseases in the year 2015, representing approximately 31% of all global deaths. The actual total worldwide volume of various cardiovascular procedures is estimated to increase daily on an average by approximately 3.7% per year to over 18.73 million, which is corresponding to prime surgeries and major transcatheter interventions in the year 2022. But also, a very less number of various interventional neuro cardiologists and different interventional neuroradiology (INR) labs, and rigid regulatory rules may basically trouble the market expansion during the estimated period.
The worldwide embolization particle market is estimated to expand at an average CAGR of 9.64% during the estimated period between 2017-2023.
There are four major regions across the globe that are majorly involved in the embolization particle market size – North America, Europe, Asia Pacific region, and Rest-of-the-World (RoW), depending upon the country-level market sizing. The embolization particle market trends are very comprehensive; you have to understand each and every player of the market. There is no debate that in spite of the occurrences of COVID 19, the latest trends and future opportunities of the market growth will see tremendous spreading opportunities.
The increasing dependence on the market supports several industries around the globe that have doubled. The embolization particle market has come up as quite compelling easy solutions. The embolization particle market has been very wide. There are lots of emerging markets related to embolization particles market all across the world, like India, China, and Brazil, that are projected to grow fast over the estimated years.
The outbreak of COVID-19 has hard severely knocked out the growing pace of the market because of mandatory closures of consumer markets and general healthcare across the globe; the profit share of the companies has been shrinking. COVID19 has disrupted the entire supply chain. A prolonged lockdown had a negative influence and affected the morale of the big pharma companies.
The embolization particle market is projected to touch the earnings of an all-time high in 2023, according to an in-depth detailed report by latest Market Research Future (MRFR). Around a CAGR of 9.64% is projected during the assessment period (2023) because of the impressive demand. Lots of factors are boosting the concept. The companies are planning and executing current business operations through innovative techniques. Many factors affect the growth of the embolization particle market, such as market size, trends in global technology, capital investment, etc.
Cumulative Growth Analysis
In case of the embolization particle market, the report claims to have a 9.64% of CAGR by 2023 and a revenue of USD 1,909.76 million by 2023. The demand and craze for it is rising, which has increased market growth. It is also estimated to increase at the most elevated speed over the given figure time frame, which is spreading or expanding across different industry verticals. Additionally, government support and customer interest are helping the market to expand. The development is primarily credited to little and medium undertakings or companies where fewer effort arrangements are significantly required.
The worldwide embolization particle market is projected to witness great substantial growth during the estimated time period because of factors, for example, increasing demand for industrialization, huge investment in oil infrastructure, development in various and large scale industries along with the huge rapid expansion is also acting as another primary growth-inducing factor.
By Division by Structure
The worldwide market is divided on the basis of various product types, modern application, level of occlusion, and end-user. It is subdivided on the basis of the product type. The advanced market is further divided into radioembolization and drug-eluting beads concepts. Again, based on the basis of various applications, the embolization particle market is divided into advanced oncology, urology methods, peripheral vascular disease, neurology issues, and others. Depending on the basis of level of various occlusion, the market is further segmented into modern proximal and distal. Based on the basis of end-user applications, it is further segmented into hospitals & clinics sections, ambulatory services, and others.
On the basis of Geographic Segmentation:
Division by Application
The primary stakeholders in the market are research organizations, Traders, Importers, and Exporters, Suppliers, Industry end users. The concept is gaining momentum. The enterprises are focusing more intensely on improving product innovation techniques.
Division by Region
The regional analysis of several embolization particle markets is being divided and studied, such as Asia Pacific, North America, European nations, and rest of the world countries. As per Geographical, North America is projected to be the biggest market in terms of profit contribution due to increased adoption of several cloud-based services by way of production systems and by several distribution channels. In addition to this, the countries of Asia Pacific are projected to grow rapidly in market due to increasing investment. Also, there has been a rise in demand in major developing countries. For example, India and China are projected to lead growth in several embolization particle demand in different Asia-Pacific regions.
There is no doubt; North America is leading the market due to the presence of the grand global players in this particular region as well as increased technological advancement.
The market players for the Market industry are:GuerbetTerumoBTG International LtdBoston Scientific CorporationMedtronicsSirtexMerit Medical
Rest of Europe
Rest of Asia-Pacific
Rest of the World
The Middle East
Market has been primarily divided into several segments, and each segment has profitable trends.
The segment is growing day by day; there is a new trend that is responsible for the growth
North America and Europe have more market share, but Asia Pacific is growing at a very fast pace.
Market overview highlights
Analysis based upon COVID 19
Explanation upon the Market Dynamics
Value chain analysis
Market segmentation overview
The regional analysis
Competitive landscape analysis
|Market Size||USD 1,430.5 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product Type, Application, Level of Occlusion, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Guerbet, Terumo, BTG International Ltd, Boston Scientific Corporation, Medtronics, Sirtex, and Merit Medical.|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Embolization Particle Market can expand at 9.64% CAGR from 2020 to 2027.
Embolization Particle Market is expected to touch USD 1,430.5 Million by 2030.
Embolization Particle Market is driven by large number of cardiovascular diseases and the emergence of minimally invasive surgeries.
Embolization Particle Market is challenged by a paucity of interventional radiology labs and interventional radiologists.
Terumo, Guerbet, BTG International Ltd, Boston Scientific Corporation, Medtronics, Sirtex, and Merit Medical are prominent players of the global embolization particle market.
Key Questions Answered
Why Choose Market Research Future?